Proteolyzed collagen cryptic bioactive epitopes

Proteolyzed collagen cryptic bioactive epitopes are specific amino acid sequences within collagen molecules that remain hidden in the native, triple-helical state but become exposed following proteolytic cleavage or structural denaturation (Brooks et al., Cell, 1998). These neoepitopes are primarily generated by the action of matrix metalloproteinases (MMPs) during active tissue remodeling processes (Xu et al., J Biol Chem, 2001). Once exposed, these sites function as potent signaling motifs that interact with cell surface receptors, such as integrins like alpha-v beta-3, to regulate critical cellular behaviors including migration, proliferation, and survival (Hangai et al., Am J Pathol, 2002). In pathological conditions like cancer and chronic inflammation, the over-exposure of these epitopes facilitates tumor-associated angiogenesis and metastasis (Heissig et al., Curr Pharm Des, 2003). Therapeutic strategies involve using monoclonal antibodies, such as HUIV26 and HUI77, to specifically bind these cryptic sites, thereby blocking their interaction with receptors and inhibiting pathological vessel growth without affecting healthy, intact collagen (Brooks et al., Cell, 1998).

Other names

Cryptic collagen sitesDenatured collagen neoepitopesMMP-cleaved collagen epitopesExposed collagen signaling motifsHUIV26 epitopeHUI77 epitope

Monoclonal antibodies selectively bind to cryptic epitopes exposed on proteolyzed collagen, preventing their interaction with integrin receptors (such as alpha-v beta-3) on endothelial cells, thereby inhibiting pathological angiogenesis and inducing apoptosis in remodeling tissues.